Sign in
Join
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
My Account
orders
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Home
Tags
Arena Pharmaceuticals
Tag: Arena Pharmaceuticals
Analyst Activity – Citigroup Reiterates Positive on Arena Pharmaceuticals (NASDAQ:ARNA)
ME Staff
-
March 21, 2018
0
Analyst Activity – JMP Securities Raises Its Price Target On Arena...
ME Staff
-
March 20, 2018
0
Analyst Activity – Citigroup Raises Its Price Target On Arena Pharmaceuticals...
ME Staff
-
February 27, 2018
0
Analyst Activity – Citigroup Raises Its Price Target On Arena Pharmaceuticals...
ME Staff
-
February 27, 2018
0
Analyst Activity – JMP Securities Raises Its Price Target On Arena...
ME Staff
-
February 20, 2018
0
Analyst Activity – Leerink Swann Reiterates Outperform on Arena Pharmaceuticals (NASDAQ:ARNA)
ME Staff
-
January 17, 2018
0
Analyst Activity – Cantor Fitzgerald Reiterates Buy on Arena Pharmaceuticals (NASDAQ:ARNA)
ME Staff
-
September 25, 2017
0
Analyst Activity – Cantor Fitzgerald Reiterates Overweight on Arena Pharmaceuticals (NASDAQ:ARNA)
ME Staff
-
July 17, 2017
0
/* */
// AST – IMS - [MarketExclusive_ROS]
